Back to results
US 6,673,332 B1Granted
Assays for inhibitors of neuronal transport of Alzheimer's amyloid precursor protein
AssigneeThe Regents of the University of California
InventorsLawrence S. B. Goldstein, Adeela Kamal, Gorazd Stokin
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and compositions for the treatment of Alzheimer's disease. In particular, the present invention provides methods and compositions suitable to assess, characterize, and identify inhibitors of neuronal transport of Alzheimer's amyloid precursor protein.
Claims13
A method for identifying modulators of transport of amyloid precursor protein comprising the steps of:
- a) providing:
- i) kinesin-I,
- ii) amyloid precursor protein, and
- iii) a test compound suspected of having modulating activity;
- b) combining said kinesin-1, said amyloid precursor protein, and said test compound under conditions such that said kinesin-I and said amyloid precursor protein will bind to produce a kinesin-I/amyloid precursor protein complex;
- and
- c) detecting modulation in the binding of said kinesin-I to said amyloid precursor protein in the presence of said test compound compared to in the absence of said test compound, thereby identifying said test compound as a modulator of transport of amyloid precursor protein.
4 more elements
Dependencies are inferred from the claim text.